Status: Recruiting
Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants
The purpose of the study is to investigate the pharmacokinetics of oral dosage of Posaconazole which is routinely administered as a standard care prophylaxis for patients undergoing cancer treatments.
Participants needed: 100
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Melbourne HealthUpdated: Feb 28, 2025Locations: 1
Eligibility criteria
Adult (≥18 years old) haematology patients receiving Posaconazole prophylaxis in... [+1]
Unable to give informed consent.